IL144828A0 - A pipecolic acid derivative containing liposome composition - Google Patents

A pipecolic acid derivative containing liposome composition

Info

Publication number
IL144828A0
IL144828A0 IL14482800A IL14482800A IL144828A0 IL 144828 A0 IL144828 A0 IL 144828A0 IL 14482800 A IL14482800 A IL 14482800A IL 14482800 A IL14482800 A IL 14482800A IL 144828 A0 IL144828 A0 IL 144828A0
Authority
IL
Israel
Prior art keywords
acid derivative
liposome composition
derivative containing
pipecolic acid
containing liposome
Prior art date
Application number
IL14482800A
Other languages
English (en)
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of IL144828A0 publication Critical patent/IL144828A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL14482800A 1999-03-11 2000-03-10 A pipecolic acid derivative containing liposome composition IL144828A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6546999 1999-03-11
JP15186699 1999-05-31
PCT/JP2000/001446 WO2000053177A1 (fr) 1999-03-11 2000-03-10 Preparations liposomiques

Publications (1)

Publication Number Publication Date
IL144828A0 true IL144828A0 (en) 2002-06-30

Family

ID=26406610

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14482800A IL144828A0 (en) 1999-03-11 2000-03-10 A pipecolic acid derivative containing liposome composition

Country Status (14)

Country Link
US (1) US6984397B2 (fr)
EP (1) EP1159962A4 (fr)
KR (1) KR20010102370A (fr)
CN (1) CN1342075A (fr)
AR (1) AR022915A1 (fr)
AU (1) AU775694B2 (fr)
BR (1) BR0010459A (fr)
CA (1) CA2364257A1 (fr)
CZ (1) CZ20013209A3 (fr)
HU (1) HUP0200483A3 (fr)
IL (1) IL144828A0 (fr)
NZ (1) NZ514046A (fr)
TR (1) TR200102778T2 (fr)
WO (1) WO2000053177A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
WO2007044748A2 (fr) * 2005-10-11 2007-04-19 University Of Pittsburgh Liposomes de sphingomyeline pour le traitement de troubles de vessie hyperactive
CN101573109A (zh) * 2006-12-28 2009-11-04 利默里克生物制药公司 用于治疗的方法和组合物
CA2693338A1 (fr) * 2007-07-31 2009-02-05 Limerick Biopharma, Inc. Analogues de pyrone phosphoryles et procedes
CA2737025C (fr) * 2008-09-27 2012-09-04 Jina Pharmaceuticals, Inc. Preparations pharmaceutiques a base de lipide(s) a usage oral et topique, leurs compositions, procedes et utilisations
CN102579437B (zh) * 2011-01-06 2014-10-29 中国医学科学院医药生物技术研究所 含醇的他克莫司组合物及其制备方法
CA2927356C (fr) * 2013-10-22 2022-08-23 Lipella Pharmaceuticals Inc. Administration d'agents a l'aide de liposomes metastables
WO2017184080A1 (fr) * 2016-04-19 2017-10-26 Nanyang Technological University Nanoliposomes pour administration prolongée de tacrolimus pour le traitement de maladies oculaires du segment antérieur
EP3512503A4 (fr) * 2016-09-14 2020-05-06 Nanyang Technological University Formulations liposomales

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880635B1 (en) 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US5089181A (en) 1987-02-24 1992-02-18 Vestar, Inc. Method of dehydrating vesicle preparations for long term storage
ATE107502T1 (de) 1988-10-05 1994-07-15 Vestar Inc Verfahren zur herstellung von liposomen mit verbesserter stabilität während des trocknens.
US5189042A (en) * 1991-08-22 1993-02-23 Merck & Co. Inc. Fluoromacrolides having immunosuppressive activity
CA2122344C (fr) * 1991-10-31 2004-04-20 Akira Kagayama Preparation de liposomes renfermant un tricyclique
GB9420390D0 (en) * 1994-10-10 1994-11-23 Nycomed Salutar Inc Liposomal agents
JPH09131348A (ja) * 1995-11-07 1997-05-20 Chugoku Kayaku Kk 血管の閉塞治療用及びガン治療用装置
ZA9710927B (en) 1996-12-06 1998-06-15 Fujisawa Pharmaceutical Co Pharmaceutical composition.
US6034135A (en) 1997-03-06 2000-03-07 Promega Biosciences, Inc. Dimeric cationic lipids
JPH1146759A (ja) * 1997-08-06 1999-02-23 Terumo Corp 細胞培養液
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6720001B2 (en) 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients

Also Published As

Publication number Publication date
BR0010459A (pt) 2002-02-05
WO2000053177A1 (fr) 2000-09-14
AU2940500A (en) 2000-09-28
AU775694B2 (en) 2004-08-12
US6984397B2 (en) 2006-01-10
EP1159962A4 (fr) 2003-07-02
CA2364257A1 (fr) 2000-09-14
TR200102778T2 (tr) 2002-05-21
US20040028728A1 (en) 2004-02-12
EP1159962A1 (fr) 2001-12-05
HUP0200483A3 (en) 2004-07-28
HUP0200483A2 (en) 2002-06-29
CN1342075A (zh) 2002-03-27
AR022915A1 (es) 2002-09-04
NZ514046A (en) 2003-10-31
KR20010102370A (ko) 2001-11-15
CZ20013209A3 (cs) 2001-12-12

Similar Documents

Publication Publication Date Title
EG24140A (en) New 3-aryl-2-hydroxypropionic acid derivative
AU2942000A (en) Novel piperidine derivatives
IL139942A0 (en) New 3-aryl-2-hydroxypropionic acid derivative iii
EP1140083A4 (fr) Nouveaux composes
HRP20000529B1 (en) Novel dihydroxyhexanoic acid derivatives
EP1249482A4 (fr) Composition d'aerosol
IL144828A0 (en) A pipecolic acid derivative containing liposome composition
HUP0201644A3 (en) Liposome compositions for improved drug retention
EG24063A (en) Novel compounds
GB9920919D0 (en) Novel compound
GB9916754D0 (en) A composition
GB9901256D0 (en) Novel compounds
GB2358508B (en) Oxygen dispenser
EP1209240A4 (fr) Nouveau compose appele f-15078
IL149405A0 (en) Compositions containing a retinoid
GB9902070D0 (en) Novel compounds
GB9905099D0 (en) A composition
SI1084101T1 (en) New 3-aryl-2-hydroxypropionic acid derivative iii
TW377580U (en) Improved structure for safety toothbrush
GB9928221D0 (en) Oxygen dispenser
GB9902935D0 (en) Novel compound
GB9905415D0 (en) Novel compound
TW485963U (en) Tape breaking structure
GB9902069D0 (en) Novel compounds
GB9901946D0 (en) Novel compounds

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)